How This Multi-Million Dollar Startup Could Make It Easier To Identify The Next Epidemic

If the virus that is now causing the COVID-19 epidemic had been detected before the first patient even showed symptoms, could the disease have been contained? Karius CEO and cofounder Mickey Kertesz hopes so. While traditional lab tests can take days and can only look for one specific disease at a time, his liquid biopsy startup is building technology to quickly detect known and emerging pathogens and, hopefully, prevent them from turning into outbreaks.
Read more